Please ask our Clinic via Contact Form Contact us for Enquiries
There is no excerpt because this is a protected post.
There are different generations in GcMAF therapy. The first generation GcMAF was developed over 20 years ago. Due to limited testing and clinical uses, the efficacy is unknown.
Thank you very much for your participation at the Saisei Mirai 2019 Integrative Medical Therapies conference in Osaka. Contents If you would like to learn more about advanced integrative medical therapies including treatments available in our clinics and treatment cases, please participate in this conference and take advantage of this great educational opportunity. – Dr Toshio Inui, CEO – This medical conference is a conference gathering of cancer therapy experts from both Japan and abroad. We will give lectures on mechanisms and cases of each treatment by domestic and international specialists including Dr Toshio Inui, CEO and Dr Shinichiro Akiyama, General Director, Saisei Mirai. All lectures will be have simulations […]
GcMAF treatment is a highly effective macrophage activating therapy, used to stimulate the immune system and activate macrophages so that they can destroy cancer cells and other abnormal cells in the body.
GcMAF (Gc Protein derived Macrophage Activating Factor) Research and references GcMAF
For the treatment for Autism Spectrum Disorders (ASD) and immune system diseases.